Inhibition by bosentan, an endothelin antagonist, of the hypersensitivity to Ca2+ channel activator evoked by salt-loading in basilar artery of stroke-prone spontaneously hypertensive rats
- 13 September 1996
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 59 (16) , PL247-PL253
- https://doi.org/10.1016/0024-3205(96)00463-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Action of the calcium channel blocker lacidipine on cardiac hypertrophy and endothelin‐1 gene expression in stroke‐prone hypertensive ratsBritish Journal of Pharmacology, 1996
- Prolonged Endothelin Blockade Reduces Hypertension and Cardiac Hypertrophy in SHR-SPJournal of Cardiovascular Pharmacology, 1995
- Selective Interaction of the Calcium Antagonist Amlodipine with Calcium Channels in Arteries of Spontaneously Hypertensive RatsJournal of Cardiovascular Pharmacology, 1994
- LacidipineJournal of Cardiovascular Pharmacology, 1994
- Different pathways of calcium sensitization activated by receptor agonists and phorbol esters in vascular smooth muscleBritish Journal of Pharmacology, 1993
- Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonistNature, 1993
- Endothelin activates voltage‐dependent Ca2+ current by a G protein‐dependent mechanism in rabbit cardiac myocytes.The Journal of Physiology, 1992
- Effect of Endothelin-1 on Calcium Channel Gating by Agonists in Vascular Smooth MuscleJournal of Cardiovascular Pharmacology, 1989
- Interactions between a ?calcium channel agonist?, Bay K 8644, and calcium antagonists differentiate calcium antagonist subgroups in K+-depolarized smooth muscleNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1984
- Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats.Circulation Research, 1977